Shares of Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) have earned an average rating of “Buy” from the six brokerages that are presently covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1 year target price among brokers that have covered the stock […]
Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Stock Rating Upgraded by StockNews.com dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reissued their buy rating on shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM – Free Report) in a report released on Monday, Benzinga reports. The brokerage currently has a $50.00 price target on the biotechnology company’s stock. HC Wainwright also issued estimates for Actinium Pharmaceuticals’ Q2 2024 earnings at ($0.38) EPS, Q3 2024 earnings at ($0.45) […]
Shares of Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) have received an average rating of “Buy” from the five research firms that are presently covering the stock, Marketbeat reports. Five equities research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokerages that have issued a report on […]
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) saw a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 1,980,000 shares, a drop of 9.6% from the March 31st total of 2,190,000 shares. Based on an average daily volume of 354,100 shares, the days-to-cover ratio […]
Actinium Pharmaceuticals, Inc. Expected to Earn FY2024 Earnings of ($1.94) Per Share (NYSEAMERICAN:ATNM) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright restated their buy rating on shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. The brokerage currently has a $50.00 price objective on the biotechnology company’s stock. Other analysts have also issued research reports about the company. B. Riley decreased their price […]
B. Riley Cuts Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Price Target to $16.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Rating) – Analysts at William Blair decreased their Q2 2023 earnings per share estimates for shares of Actinium Pharmaceuticals in a research report issued on Tuesday, May 16th. William Blair analyst A. Hsieh now expects that the biotechnology company will earn ($0.58) per share for the quarter, down from […]
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Rating) – HC Wainwright dropped their FY2025 EPS estimates for shares of Actinium Pharmaceuticals in a report released on Monday, April 3rd. HC Wainwright analyst J. Pantginis now forecasts that the biotechnology company will earn $1.34 per share for the year, down from their previous forecast of $1.49. HC […]